by admin | Jan 10, 2021
TCR2 Therapeutic (TCRR) was a successful small cap Biotech in 2020 with shares gaining around 100% and will be presenting at the JP Morgan Healthcare Conference this week on 1-14-.
TCRR is a clinical-stage immunotherapy company developing the next...
Please login to continue reading this article.
Options Hawk Max
$300 | 30 days
More About this Plan
Options Hawk Elite
$149 | 30 days